Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dominguez

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
JAMA|February 14, 2013
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communitiesDouglas R Morgan, Javier Torres, Rachael Sexton, et al.
Lancet (London, England)|July 23, 2011
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialE Robert Greenberg, Garnet L Anderson, Douglas R Morgan, et al.
Iscience|November 15, 2023
TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse modelsSara L Dominguez, Benjamin I Laufer, Arundhati Sengupta Ghosh, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2026
Randomized, Double-blind, Placebo-controlled Trial of Meriva® (curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisMaria Gonzalez-Pons, Ricardo L Dominguez, Eleazar E Montalvan-Sanchez, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 InhibitorBryan K Chan, Anthony A Estrada, Huifen Chen, et al.
Science Translational Medicine|December 18, 2012
Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutationsZejuan Sheng, Shuo Zhang, Daisy Bustos, et al.
MMWR. Morbidity and Mortality Weekly Report|April 1, 2016
Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016Naomi K Tepper, Howard I Goldberg, Manuel I Vargas Bernal, et al.
The Journal of Clinical Investigation|May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockadeAmber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
JAMA|February 14, 2013
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communitiesDouglas R Morgan, Javier Torres, Rachael Sexton, et al.
Lancet (London, England)|July 23, 2011
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialE Robert Greenberg, Garnet L Anderson, Douglas R Morgan, et al.
Iscience|November 15, 2023
TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse modelsSara L Dominguez, Benjamin I Laufer, Arundhati Sengupta Ghosh, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2026
Randomized, Double-blind, Placebo-controlled Trial of Meriva® (curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisMaria Gonzalez-Pons, Ricardo L Dominguez, Eleazar E Montalvan-Sanchez, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 InhibitorBryan K Chan, Anthony A Estrada, Huifen Chen, et al.
Science Translational Medicine|December 18, 2012
Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutationsZejuan Sheng, Shuo Zhang, Daisy Bustos, et al.
MMWR. Morbidity and Mortality Weekly Report|April 1, 2016
Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016Naomi K Tepper, Howard I Goldberg, Manuel I Vargas Bernal, et al.
The Journal of Clinical Investigation|May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockadeAmber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Pageof 29